LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

trial results for anti thrombotic and stroke prevention effects in comparison with aspirin - presumably is still "work in progress", so if those come out as unproven or similar, then presumably sp will plummet.

No, not in but I have twice made a small profit...looking at the sp : should have stayed put...it's just that competing with aspirin....?...there will be years of tests and at what price on the market ?.....the beat thing with this stock is to trade it up and down and forget about what it does ! or does not.

earlier trials showed the effects were there - so unproven is not on the agenda - this larger trial is a comparitive study, published results are expected shortly. They are not showing if it works but how it works at in comparison to aspirin. ie effects and side effects. Even if it works less effectively ( very unlikely) it has no demonstrated side effects so would be a safer option - aspirin can cause gastric bleeding and ulcers amongst other side effects but people take that risk to avoid more serious conditions! It may even mean it can be sold at at higher price if it is a superior product.

Guys....I know I'm not in but on this new peak ; take at least 25% profits...it's still very risky.

thanks GN .... i already knew about the side effects of aspirin .....

surely if it is a "comparative study", by implication it is to show (or otherwise) that fruitflow is at least as effective as aspirin and without the side-effects - i.e. the earlier trial only indicated that it might (well) be

the how and why fruitflow works, if that is indeed the case, is surely more of scientific interest than relevance to the layman.

even the layman has some need to know that what he is taking has been tested and proven especially when it comes to health. The layman should have more than a passing interest in science but maybe that's too hopeful!

yes and no ..... layman only wants to know that is has been shown to work and to do so safely; the why and how or even interest in same, is far beyond the mental capacity of the Great Unwashed

Well ...we haven't had any tomato jokes yet..."pulp fiction" style ....ketchup.....and sorts....mummy tomato... daddy tomato...baby tomato...

if sp collapses, there'll sure be a few rotten ones flying about

wrong news........wait for the rotten tomatoes .....fund raising

RNS more shares to be placed to raise 5m.

there it goes........

11.75 10.05am

going back up?

might be sensible to sit this one out until the dust settles.

not necessarily that bearish .....

Provexis plc notes the recent share price movement and announces that it is in discussions with certain institutional investors and high net worth individuals regarding a potential subscription of new ordinary shares to raise approximately 5 million ('Subscription') at a significant discount to the current share price. If the Subscription were to proceed, the Board intends as soon as reasonably practicable to undertake an open offer or an offer for subscription to be made available to all shareholders to subscribe for new shares in the Company at the same price as the Subscription, subject to prevailing market conditions. There is no guarantee that the Subscription will proceed. The Company will make a further announcement in due course.

gadzooks! as one might say .... serves me right for not doing as i promised myself last night ....... just goes to show how fragile this sort of company and its sp are

do you read that as 5m from institutions and further money from everyone else or that they are looking for 5m total. It's still a small sum of money and not decided yet but clearly it has spooked many.

holding on and waiting for the news that made this a good time to approach institutional investors

i assumed it was just 5m in total which really is peanuts, but on re-reading it is indeed pretty ambiguous

what a day.....